Treatment With IV Iron in Hospitalized Patients With Severe Heart Failure But Without Iron Deficiency
Status:
Withdrawn
Trial end date:
2018-02-06
Target enrollment:
Participant gender:
Summary
Patients with congestive heart failure, grade 3-4, in addition to the standard care, will be
randomized 1:1. The study group will receive 2 doses of IV iron (Iron carboxymaltose). The
control group will receive standard of care alone. The study will test for the effects of the
additional IV iron on the symptoms, clinical picture and quality of life of the treated
patients.